Isolation and identification of phase I metabolites of butyrolactone I in rats

References

• Aurelio SM, Juana R, Inmaculada V, et al (2011). New butyrolactone from a marine-derived fungus Aspergillus sp. J Chil Chem Soc 56:625–7.
   Web of Science ®Google Scholar
• Bai X, Xie YY, Liu J, et al (2010). Isolation and identification of urinary metabolites of kakkalide in rats. Drug Metab Dispos 38:281–6.
   PubMed Web of Science ®Google Scholar
• Bari LD, Pescitelli G, Pratelli C, et al (2001). Determination of absolute configuration of acyclic 1,2-diols with Mo2(OAc)4. 1. Snatzke's method revisited. J Org Chem 66:4819–25.
   PubMed Web of Science ®Google Scholar
• Cazar ME, Schmeda-Hirschmann G, Astudillo L. (2005). Antimicrobial butyrolactone I derivatives from the ecuadorian soil fungus Aspergillus terreus thorn. var terreus. World J Microb Biot 21:1067–75.
   Web of Science ®Google Scholar
• Dewi RT, Tachibana S, Itoh K, Ilyas M. (2012a). Isolation of antioxidant compounds from Aspergillus terreus. J Microb Biochem Tech 4:10–14.
   Google Scholar
• Dewi RT, Tachibana S, Itoh K, Ilyas M. (2012b). Antidiabetic and antioxidative activities of butyrolactone I from Aspergillus terreus MC751. World Aca Sci. Eng Technol 6:820–5.
   Google Scholar
• Frelek J, Szczepek WJ. (1999). [Rh2(O2CCF3)4] as an auxiliary chromophore in chiroptical studies on steroidal alcohols. Tetrahedron: Asymmetry 10:1507–20.
   Web of Science ®Google Scholar
• Frelek J, Ruśkowska P, Suszczyńska A, et al (2008). Configurational assignment of sugar erythro-1, 2-diols from their electronic circular dichroism spectra with dimolybdenum tetraacetate. Tetrahedron Asymmetry 19:1709–13.
   Web of Science ®Google Scholar
• Gerards M, Snatzke G. (1990). Circular dichroism, XCIII’ determination of the absolute configuration of alcohols, olefins, epoxides, and ethers from the CD of their “in situ” complexes with [Rh2(O2CCF3)4]. Tetrahedron: Asymmetry 1:221–36.
   Web of Science ®Google Scholar
• Gong T, Dong SH, Zhu P. (2014). Butyrolactone derivatives isolated from the marine fungus Aspergillus versicolor F62. Mycosystema 33:706–12.
   Google Scholar
• Haritakun R, Rachtawee P, Chanthaket R, et al (2010). Butyrolactones from the fungus Aspergillus terreus BCC 4651. Chem Pharm Bull 58:1545–8.
   PubMed Web of Science ®Google Scholar
• He F, Bao J, Zhang XY, et al (2013). Asperterrestide A, a cytotoxic cyclic tetrapeptide from the marine-derived fungus Aspergillus terreus SCSGAF0162. J Nat Prod 76:1182–6.
   PubMed Web of Science ®Google Scholar
• Huwe A, Mazitschek R, Giannis A. (2003). Small molecules as inhibitors of cyclin-dependent kinases. Angew Chem Int Ed Engl 42:2122–38.
   PubMed Web of Science ®Google Scholar
• Kiriyama N, Nitta K, Sakaguchi Y, et al (1977). Bioactive metabolites from Penicillium sp., an endophytic fungus residing in Hopea hainanensis. Chem Pharm Bull 25:2593–601.
   Web of Science ®Google Scholar
• Kitagawa M, Okabe T, Ogino H, et al (1993). Butyrolactone I, a selective inhibitor of cdk2 and cdc2 kinase. Oncogene 8:2425–32.
   PubMed Web of Science ®Google Scholar
• Kitagawa M, Higashi H, Takahashi IS, et al (1994). Cyclin dependent kinase inhibitor, butyrolactone I, inhibits phosphorylation of RB protein and cell cycle progression. Oncogene 9:2549–57.
   PubMed Web of Science ®Google Scholar
• Leal CLV, Mamo1 S, Fair1 T, Lonergan P. (2012). Gene expression in bovine oocytes and cumulus cells after meiotic inhibition with the cyclin-dependent kinase inhibitor butyrolactone I. Reprod Dom Anim 47:615–24.
   PubMed Web of Science ®Google Scholar
• Li C, Yao ZH, Qin ZF, et al (2014). Isolation and identification of phase I metabolites of phillyrin in rats. Fitoterapia 97:92–7.
   PubMed Web of Science ®Google Scholar
• Lu KP, Hunter T. (1995). Evidence for a NIMA like mitotic pathway in vertebrate cells. Cell 81:413–24.
   PubMed Web of Science ®Google Scholar
• Lv X, Wang CY, Hou J, et al (2012). Isolation and identification of metabolites of osthole in rats. Xenobiotica 42:1120–7.
   PubMed Web of Science ®Google Scholar
• Ma XH, Zhu TJ, Gu QQ, et al (2014). Structures and antiviral activities of butyrolactone derivatives isolated from Aspergillus terreus MXH-23. Ocean Coas Sea Res 13:1067–70.
   Google Scholar
• Markus MA, Kahle PJ, Winkler A, et al (1997). Survival-promoting activity of inhibitors of cyclin-dependent kinases on primary neurons correlates with inhibition of c-Jun kinase-1. Neurobiol Dis 4:122–3.
   PubMed Web of Science ®Google Scholar
• NCCLS. (2000). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically-fifth edition: approved standard M7-A5. Vol. 20. Wayne, PA: National Committee on Clinical Laboratory Standards.
   Google Scholar
• Nishio K, Ishida T, Arioka H, et al (1996). Antitumor effects of butyrolactone I, a selective cdc2 kinase inhibitor, on human lung cancer cell lines. Anticancer Res 16:3387–96.
   PubMed Web of Science ®Google Scholar
• Okumura E, Sekiai T, Hisanaga S, et al (1996). Initial triggering of M-phase in starfish oocytes: a possible novel component of maturation-promoting factor besides cdc2 kinase. J Cell Biol 132:125–35.
   PubMed Web of Science ®Google Scholar
• Rateb ME, Houssen WE, Legrave NM, et al (2010). Dibenzofurans from the marine sponge-derived ascomycete Super1F1-09. Botanica Marina 53:499–506.
   Web of Science ®Google Scholar
• Rüfer CE, Glatt H, Kulling SE. (2006). Structural elucidation of hydroxylated metabolites of the isoflavan equol by gas chromatography-mass spectrometry and high-performance liquid chromatography-mass spectrometry. Drug Metab Dispos 34:51–60.
   PubMed Web of Science ®Google Scholar
• Sax JK, Dash BC, Hong R, et al (2002). The cyclin-dependent kinase inhibitor butyrolactone is a potent inhibitor of p21 WAF1/CIP1 expression. Cell Cycle 1:90–6.
   PubMed Web of Science ®Google Scholar
• Suzuki M, Hosaka Y, Matsushima H, et al (1999). Butyrolactone I induces cyclin B1 and causes G2/M arrest and skipping of mitosis in human prostate cell lines. Cancer Lett 138:121–30.
   PubMed Web of Science ®Google Scholar
• Wang PL, Zhang FX, Qiu ZC, et al (2016). Isolation and identification of metabolites of bakuchiol in rats. Fitoterapia 109:31–8.
   PubMed Web of Science ®Google Scholar
• Xu F, Zhang Y, Xiao S, et al (2006). Absorption and metabolism of Astragali radix decoction: in silico, in vitro, and a case study in vivo. Drug Metab Dispos 34:913–24.
   PubMed Web of Science ®Google Scholar
• Yang XW, Xing ZT, Cui JR, et al (2001). Studies on the metabolism of cinbifagin and cinbufotalin by human intestinal bacteria. J Peking Univ (Hlth Sci) 33:199–204.
   Web of Science ®Google Scholar
• Zeng YC, Qiu F, Liu Y, et al (2007). Isolation and identification of phase 1 metabolites of demethoxycurcumin in rats. Drug Metab Dispos 35:1564–73.
   PubMed Web of Science ®Google Scholar